{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:02:48Z","timestamp":1786996968360,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.soc.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T08:02:20Z","timestamp":1479974540000},"page":"17-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Human Immunodeficiency Virus\/AIDS, Human Papillomavirus, and Anal Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Chia-ching J.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sparano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrclinonc.2013.84","article-title":"Clinical trials of human papillomavirus vaccines and beyond","volume":"10","author":"Lehtinen","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.soc.2016.07.010_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.soc.2016.07.010_bib4","first-page":"1634","article-title":"Management of anal cancer in the HIV-positive population","volume":"19","author":"Kauh","year":"2005","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/LGT.0b013e31827ed372","article-title":"Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction","volume":"17","author":"Steinau","year":"2013","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib9","first-page":"57","article-title":"The role of human papillomavirus in nongenital cancers","volume":"63","author":"Zandberg","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2016.07.010_bib10","first-page":"1","article-title":"Human papillomaviruses","volume":"90","year":"2007","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"11","key":"10.1016\/j.soc.2016.07.010_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/0956462413481527","article-title":"Anal intraepithelial neoplasia: review and recommendations for screening and management","volume":"24","author":"Smyczek","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"49","key":"10.1016\/j.soc.2016.07.010_bib12","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1016\/j.vaccine.2008.07.056","article-title":"Prophylactic HPV vaccines: new interventions for cancer control","volume":"26","author":"Barr","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.soc.2016.07.010_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","article-title":"The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States","volume":"17","author":"Giuliano","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/EDE.0b013e3181c1e70b","article-title":"Human papillomavirus infections among couples in new sexual relationships","volume":"21","author":"Burchell","year":"2010","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/jis327","article-title":"Genital human papillomavirus (HPV) concordance in heterosexual couples","volume":"206","author":"Nyitray","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.soc.2016.07.010_bib17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jir644","article-title":"Genital transmission of human papillomavirus in recently formed heterosexual couples","volume":"204","author":"Burchell","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ijc.24097","article-title":"Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study","volume":"124","author":"Giuliano","year":"2009","journal-title":"Int J Cancer"},{"issue":"9769","key":"10.1016\/j.soc.2016.07.010_bib19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib20","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3390\/v7072802","article-title":"Human papillomaviruses; epithelial tropisms, and the development of neoplasia","volume":"7","author":"Egawa","year":"2015","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.soc.2016.07.010_bib21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00018-009-8631-7","article-title":"The regulation of cell proliferation by the papillomavirus early proteins","volume":"66","author":"Hamid","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 5","key":"10.1016\/j.soc.2016.07.010_bib22","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virol.2011.12.018","article-title":"Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses","volume":"424","author":"Klingelhutz","year":"2012","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"32","author":"Darragh","year":"2013","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"10.1016\/j.soc.2016.07.010_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/jnci\/dji163","article-title":"Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study","volume":"97","author":"Chin-Hong","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.OLQ.0000109515.75864.2B","article-title":"High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy","volume":"31","author":"Piketty","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/424599","article-title":"Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy","volume":"190","author":"Wilkin","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.OLQ.0000430798.61475.08","article-title":"Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men","volume":"40","author":"Darwich","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/597207","article-title":"Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study","volume":"199","author":"de Pokomandy","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.soc.2016.07.010_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/sti.2008.034744","article-title":"Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men","volume":"85","author":"Vajdic","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/QAD.0000000000000254","article-title":"Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM","volume":"28","author":"Hernandez","year":"2014","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00042560-199804010-00004","article-title":"Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men","volume":"17","author":"Palefsky","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.soc.2016.07.010_bib33","unstructured":"UNAIDS, Fact sheet. 2015. Available at: http:\/\/www.unaids.org\/en\/resources\/campaigns\/HowAIDSchangedeverything\/factsheet. 2015. Accessed April 1, 2016."},{"key":"10.1016\/j.soc.2016.07.010_bib34","unstructured":"Centers for Disease Control and Prevention (CDC). HIV in the United States: at a glance. 2015. Available at: http:\/\/www.cdc.gov\/hiv\/statistics\/overview\/ataglance.html. Accessed April 1, 2016."},{"issue":"20","key":"10.1016\/j.soc.2016.07.010_bib35","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","article-title":"Impact of the HIV epidemic on the incidence rates of anal cancer in the United States","volume":"104","author":"Shiels","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.soc.2016.07.010_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/596766","article-title":"Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 Survey","volume":"48","author":"Bonnet","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9581","key":"10.1016\/j.soc.2016.07.010_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.soc.2016.07.010_bib38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","article-title":"Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000","volume":"28","author":"Morlat","year":"2014","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","article-title":"Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America","volume":"54","author":"Silverberg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.soc.2016.07.010_bib41","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib42","doi-asserted-by":"crossref","first-page":"dju503","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2016.07.010_bib43","unstructured":"Howlader N, Noone AM, Krapcho M, et\u00a0al. SEER Cancer statistics review, 1975-2012. Based on November 2014 SEER data submission. Bethesda (MD): National Cancer Institute."},{"key":"10.1016\/j.soc.2016.07.010_bib44","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/QAD.0000000000001077","article-title":"Cancer risk among the HIV-infected elderly in the United States","volume":"30","author":"Yanik","year":"2016","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwr146","article-title":"Use of Surveillance, Epidemiology, and End Results\u2013Medicare data to conduct case-control studies of cancer among the US elderly","volume":"174","author":"Engels","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"9034","key":"10.1016\/j.soc.2016.07.010_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.soc.2016.07.010_bib47","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib48","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.soc.2016.07.010_bib49","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib51","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib52","first-page":"39","article-title":"Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest Cancer Res"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/BF02052589","article-title":"Squamous-cell carcinoma of the anus in HIV-positive patients","volume":"37","author":"Chadha","year":"1994","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.soc.2016.07.010_bib55","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0360-3016(96)00596-2","article-title":"Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal","volume":"37","author":"Peddada","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.soc.2016.07.010_bib56","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02234322","article-title":"Outcome analysis of HIV-positive patients with anal squamous cell carcinoma","volume":"44","author":"Place","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiology.193.1.8090901","article-title":"Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy","volume":"193","author":"Holland","year":"1994","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib60","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s10350-004-0910-7","article-title":"Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy","volume":"48","author":"Blazy","year":"2005","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/annonc\/mdr050","article-title":"Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression","volume":"23","author":"Alfa-Wali","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2016.07.010_bib62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/JCO.2007.14.2810","article-title":"Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era","volume":"26","author":"Chiao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?","volume":"98","author":"Fraunholz","year":"2011","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2008.10.046","article-title":"Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients","volume":"75","author":"Seo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.soc.2016.07.010_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/DCR.0b013e31819eefa6","article-title":"HIV and anal cancer outcomes: a single institution's experience","volume":"52","author":"Hogg","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib67","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/DCR.0b013e3182137de9","article-title":"Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: a comparative study","volume":"54","author":"Munoz-Bongrand","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"15","key":"10.1016\/j.soc.2016.07.010_bib68","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","article-title":"HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy","volume":"26","author":"Oehler-Janne","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12029-013-9543-1","article-title":"HIV positivity but not HPV\/p16 status is associated with higher recurrence rate in anal cancer","volume":"44","author":"Meyer","year":"2013","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"12","key":"10.1016\/j.soc.2016.07.010_bib70","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/DCR.0000000000000476","article-title":"HIV infection is associated with poor outcomes for patients with anal cancer in the highly active antiretroviral therapy era","volume":"58","author":"Grew","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib71","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-003-0111-z","article-title":"The biochemical and biological functions of human papillomavirus type 16 E5 protein","volume":"148","author":"Tsai","year":"2003","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/X4UADHVN317V2XMW","article-title":"Epidermal growth factor receptor expression in anal canal carcinoma","volume":"124","author":"Le","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.soc.2016.07.010_bib73","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/bjc.2012.479","article-title":"EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?","volume":"107","author":"Paliga","year":"2012","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.soc.2016.07.010_bib74","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2165\/00003495-200767170-00008","article-title":"Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.soc.2016.07.010_bib77","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM200104123441503","article-title":"Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck","volume":"344","author":"Mork","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.soc.2016.07.010_bib78","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study","volume":"95","author":"Herrero","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.soc.2016.07.010_bib79","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.soc.2016.07.010_bib80","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/annonc\/mdn372","article-title":"HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007)","volume":"19","author":"Termine","year":"2008","journal-title":"Ann Oncol"},{"issue":"34","key":"10.1016\/j.soc.2016.07.010_bib81","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","article-title":"Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study","volume":"23","author":"Burtness","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.soc.2016.07.010_bib82","article-title":"Phase II trials of cetuximab (CX) plus cisplatin (CDDP), 5fluorouracil (5FU) and radiation (RT) in immunocompetent (ECOG 3205) and HIVpositive (AMC045) patients with squamous cell carcinoma of the anal canal (SCAC): safety and preliminary efficacy results","volume":"30","author":"Garg","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.soc.2016.07.010_bib83","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11 Pt 1","key":"10.1016\/j.soc.2016.07.010_bib84","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1158\/1078-0432.CCR-05-2434","article-title":"Tumor-infiltrating cytotoxic T\u00a0cells but not regulatory T\u00a0cells predict outcome in anal squamous cell carcinoma","volume":"12","author":"Grabenbauer","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.soc.2016.07.010_bib85","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1470-2045(11)70056-0","article-title":"Use of antineoplastic agents in patients with cancer who have HIV\/AIDS","volume":"12","author":"Rudek","year":"2011","journal-title":"Lancet Oncol"},{"issue":"33","key":"10.1016\/j.soc.2016.07.010_bib86","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib87","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib89","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel","volume":"312","author":"Gunthard","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.soc.2016.07.010_bib90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A\u00a0review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"J\u00a0Med Toxicol"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib91","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/cncr.28554","article-title":"A\u00a0phase 1\/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061","volume":"120","author":"Rudek","year":"2014","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.soc.2016.07.010_bib92","first-page":"5230","article-title":"The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells","volume":"62","author":"Pajonk","year":"2002","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.soc.2016.07.010_bib94","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/9498","article-title":"Effect of interleukin-2 on the pool of latently infected, resting CD4+ T\u00a0cells in HIV-1-infected patients receiving highly active anti-retroviral therapy","volume":"5","author":"Chun","year":"1999","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.soc.2016.07.010_bib95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","article-title":"Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease","volume":"57","author":"Fraunholz","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"RR-4","key":"10.1016\/j.soc.2016.07.010_bib96","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib97","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2008.0013","article-title":"Prevention and treatment of cancer-related infections","volume":"6","author":"Segal","year":"2008","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.soc.2016.07.010_bib98","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1200\/JCO.1995.13.7.1632","article-title":"Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group","volume":"13","author":"Bunn","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.soc.2016.07.010_bib99","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib100","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/656320","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men","volume":"202","author":"Wilkin","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.soc.2016.07.010_bib101","unstructured":"AIDS Malignancy Consortium. Vaccine therapy in preventing human papillomavirus infection in young HIV-positive male patients who have sex with males. In: clinicaltrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01209325. Accessed March 18, 2016."},{"issue":"10","key":"10.1016\/j.soc.2016.07.010_bib102","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/cid\/civ628","article-title":"Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men","volume":"61","author":"Deshmukh","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.soc.2016.07.010_bib103","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A\u00a09-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.soc.2016.07.010_bib104","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","article-title":"Anal cancer: an overview","volume":"12","author":"Uronis","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.soc.2016.07.010_bib105","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/21645515.2016.1149274","article-title":"Prophylactic HPV vaccination and anal cancer","volume":"12","author":"Stier","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.soc.2016.07.010_bib106","unstructured":"AIDS Malignancy Consortium. Topical or ablative treatment in preventing anal\u00a0cancer in patients with HIV and anal high-grade squamous intraepithelial lesions. In: clinicaltrials.gov. Available at: https:\/\/clinicaltrials.gov\/show\/NCT02135419. Accessed March 18, 2016."},{"issue":"3","key":"10.1016\/j.soc.2016.07.010_bib107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/DCR.0000000000000058","article-title":"Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer","volume":"57","author":"Goldstone","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.soc.2016.07.010_bib108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11908-010-0090-7","article-title":"Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men","volume":"12","author":"Park","year":"2010","journal-title":"Curr Infect Dis Rep"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2016.07.010_bib109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1463-1318.2010.02494.x","article-title":"Guidelines for management of anal intraepithelial neoplasia","volume":"13","author":"Scholefield","year":"2011","journal-title":"Colorectal Dis"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:00:34Z","timestamp":1760961634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320716300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1055320716300436"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2016.07.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Immunodeficiency Virus\/AIDS, Human Papillomavirus, and Anal Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}